ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04662	B cell receptor signaling pathway	6/32	88/7206	1.96150001882e-06
ko05222	Small cell lung cancer	6/32	89/7206	2.09675579188e-06
ko04658	Th1 and Th2 cell differentiation	6/32	96/7206	3.27284533741e-06
ko04151	PI3K-Akt signaling pathway	10/32	390/7206	4.2372173208e-06
ko05200	Pathways in cancer	11/32	492/7206	4.64986245192e-06
ko05161	Hepatitis B	7/32	173/7206	8.25478562971e-06
ko04660	T cell receptor signaling pathway	6/32	124/7206	1.44471484099e-05
ko05166	HTLV-I infection	8/32	292/7206	2.96860888864e-05
ko04659	Th17 cell differentiation	5/32	106/7206	9.19713815294e-05
ko04218	Cellular senescence	6/32	177/7206	0.00010748041878
ko05215	Prostate cancer	5/32	111/7206	0.000114504741335
ko05167	Kaposi's sarcoma-associated herpesvirus infection	6/32	191/7206	0.000163463134187
ko04668	TNF signaling pathway	5/32	120/7206	0.000165524647297
ko04015	Rap1 signaling pathway	7/32	278/7206	0.000173012556551
ko04014	Ras signaling pathway	7/32	279/7206	0.000176915501159
ko05145	Toxoplasmosis	5/32	126/7206	0.000208160264852
ko04380	Osteoclast differentiation	5/32	134/7206	0.000277504678138
ko04931	Insulin resistance	5/32	137/7206	0.000307599101085
ko04010	MAPK signaling pathway	7/32	321/7206	0.000418560935228
ko05131	Shigellosis	4/32	82/7206	0.000439510661583
ko04360	Axon guidance	6/32	233/7206	0.000479150013646
ko05220	Chronic myeloid leukemia	4/32	85/7206	0.000504070631681
ko04510	Focal adhesion	6/32	240/7206	0.000560916215817
ko04611	Platelet activation	5/32	163/7206	0.000683953377534
ko04623	Cytosolic DNA-sensing pathway	3/32	41/7206	0.000756252380226
ko04620	Toll-like receptor signaling pathway	4/32	100/7206	0.000931703965758
ko04210	Apoptosis	5/32	180/7206	0.00107108280419
ko04024	cAMP signaling pathway	6/32	279/7206	0.00123576820716
ko04022	cGMP-PKG signaling pathway	5/32	216/7206	0.00240264766194
ko04622	RIG-I-like receptor signaling pathway	3/32	62/7206	0.00251870929599
ko05221	Acute myeloid leukemia	3/32	63/7206	0.00263670499203
ko04933	AGE-RAGE signaling pathway in diabetic complications	4/32	135/7206	0.00282019341462
ko05160	Hepatitis C	4/32	153/7206	0.00442332917156
ko04512	ECM-receptor interaction	3/32	79/7206	0.00500423761433
ko04722	Neurotrophin signaling pathway	4/32	160/7206	0.00518544806215
ko05212	Pancreatic cancer	3/32	83/7206	0.00574499447746
ko05164	Influenza A	4/32	167/7206	0.00603161610733
ko05218	Melanoma	3/32	85/7206	0.006138798659
ko04920	Adipocytokine signaling pathway	3/32	89/7206	0.00697412320272
ko05206	MicroRNAs in cancer	4/32	177/7206	0.0073941122665
ko01523	Antifolate resistance	2/32	30/7206	0.00769093102971
ko04064	NF-kappa B signaling pathway	3/32	96/7206	0.00859230193264
ko04650	Natural killer cell mediated cytotoxicity	3/32	97/7206	0.00884000373356
ko00073	Cutin, suberine and wax biosynthesis	1/32	2/7206	0.00886238104845
ko05146	Amoebiasis	3/32	99/7206	0.00934797194527
ko05169	Epstein-Barr virus infection	4/32	206/7206	0.0124604301119
ko05162	Measles	3/32	120/7206	0.0157186557144
ko04211	Longevity regulating pathway	3/32	123/7206	0.0167866480139
ko05142	Chagas disease (American trypanosomiasis)	3/32	130/7206	0.0194348851306
ko04919	Thyroid hormone signaling pathway	3/32	143/7206	0.0249373349071
ko05321	Inflammatory bowel disease (IBD)	2/32	56/7206	0.0253476735633
ko04962	Vasopressin-regulated water reabsorption	2/32	58/7206	0.0270588196204
ko04810	Regulation of actin cytoskeleton	4/32	264/7206	0.0282743838351
ko04621	NOD-like receptor signaling pathway	3/32	157/7206	0.031715094918
ko05418	Fluid shear stress and atherosclerosis	3/32	173/7206	0.0405358395106
ko05224	Breast cancer	3/32	174/7206	0.0411247870906
ko05030	Cocaine addiction	2/32	73/7206	0.0412896956691
ko05140	Leishmaniasis	2/32	75/7206	0.0433619526423
ko04310	Wnt signaling pathway	3/32	181/7206	0.0453699494134
ko05130	Pathogenic Escherichia coli infection	2/32	77/7206	0.0454727256815
ko04370	VEGF signaling pathway	2/32	77/7206	0.0454727256815
ko04932	Non-alcoholic fatty liver disease (NAFLD)	3/32	182/7206	0.0459938108189
ko05214	Glioma	2/32	79/7206	0.0476212168234
ko05230	Central carbon metabolism in cancer	2/32	81/7206	0.0498066384376